Cargando…

Impact of IL28B Genetic Variation on HCV-Induced Liver Fibrosis, Inflammation, and Steatosis: A Meta-Analysis

BACKGROUND & AIMS: IL28B polymorphisms were shown to be strongly associated with the response to interferon therapy in chronic hepatitis C (CHC) and spontaneous viral clearance. However, little is known about how these polymorphisms affect the natural course of the disease. Thus, we conducted th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Masaya, Kondo, Mayuko, Tateishi, Ryosuke, Fujiwara, Naoto, Kato, Naoya, Yoshida, Haruhiko, Taguri, Masataka, Koike, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956722/ https://www.ncbi.nlm.nih.gov/pubmed/24637774 http://dx.doi.org/10.1371/journal.pone.0091822

Ejemplares similares

Changes in Risk of Immediate Adverse Reactions to Iodinated Contrast Media by Repeated Administrations in Patients with Hepatocellular Carcinoma
por: Fujiwara, Naoto, et al.
Publicado: (2013)

Frequency of and Predictive Factors for Vascular Invasion after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Asaoka, Yoshinari, et al.
Publicado: (2014)

Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma
por: Enooku, Kenichiro, et al.
Publicado: (2019)

IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF Signal
por: Okushin, Kazuya, et al.
Publicado: (2012)

Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors
por: Shiina, Shuichiro, et al.
Publicado: (2012)

Eradication of hepatitis C virus is associated with the attenuation of steatosis as evaluated using a controlled attenuation parameter
por: Shimizu, Kohei, et al.
Publicado: (2018)

Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients
por: Minami, Tatsuya, et al.
Publicado: (2015)

Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation
por: Uchino, Koji, et al.
Publicado: (2018)

Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients
por: Enooku, Kenichiro, et al.
Publicado: (2018)

Host genetics of HCV disease — IL28B
por: Fellay, J
Publicado: (2010)

Machine-learning Approach for the Development of a Novel Predictive Model for the Diagnosis of Hepatocellular Carcinoma
por: Sato, Masaya, et al.
Publicado: (2019)

Frequency, Risk Factors and Survival Associated with an Intrasubsegmental Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Tateishi, Ryosuke, et al.
Publicado: (2013)

Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study
por: Tateishi, Ryosuke, et al.
Publicado: (2014)

CT With Hepatic Arterioportography as a Pretreatment Examination for Hepatocellular Carcinoma Patients: A Randomized Controlled Trial
por: Ohki, Takamasa, et al.
Publicado: (2013)

Impact of Immunogenetic IL28B Polymorphism on Natural Outcome of HCV Infection
por: De Re, Valli, et al.
Publicado: (2014)

EPSTI1 Is Involved in IL-28A-Mediated Inhibition of HCV Infection
por: Meng, Xianghe, et al.
Publicado: (2015)

Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism
por: Zoller, Heinz, et al.
Publicado: (2015)

Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
por: Shiina, Shuichiro, et al.
Publicado: (2012)

In-hospital mortality associated with transcatheter arterial embolization for treatment of hepatocellular carcinoma in patients on hemodialysis for end stage renal disease: a matched-pair cohort study using a nationwide database
por: Sato, Masaya, et al.
Publicado: (2019)

Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
por: Tanaka, Yasuo, et al.
Publicado: (2018)

No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV
por: Fernández-Montero, JV, et al.
Publicado: (2010)

Hepatitis C Virus (HCV) Infection and Hepatic Steatosis
por: Yoon, Eugene J., et al.
Publicado: (2006)

HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2
por: De Re, Valli, et al.
Publicado: (2016)

Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antivirals
por: Fukumoto, Tsuyoshi, et al.
Publicado: (2022)

Histopathological validation of magnifying endoscopy for diagnosis of mixed-histological-type early gastric cancer
por: Ozeki, Yuichiro, et al.
Publicado: (2020)

Pharmacogenetics of Efficacy and Safety of HCV Treatment in HCV-HIV Coinfected Patients: Significant Associations with IL28B and SOCS3 Gene Variants
por: Vidal, Francesc, et al.
Publicado: (2012)

Treatment and outcome of hepatorenal syndrome in Japan: a retrospective cohort study using a national inpatient database
por: Okushin, Kazuya, et al.
Publicado: (2023)

Utility of hepatic vein waveform and transient elastography in patients with Budd–Chiari syndrome who require angioplasty: Two case reports
por: Nakatsuka, Takuma, et al.
Publicado: (2019)

IL28B SNP genotyping among Iranian HCV-infected patients: A preliminary report
por: Mahboobi, Nastaran, et al.
Publicado: (2011)

The Association of Il28b Genotype with the Histological Features of Chronic Hepatitis C Is HCV Genotype Dependent
por: D’Ambrosio, Roberta, et al.
Publicado: (2014)

Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis
por: Sekino, Yuta, et al.
Publicado: (2022)

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
por: Stevenson, Heather L., et al.
Publicado: (2016)

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
por: Martinez, Valrie, et al.
Publicado: (2012)

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals
por: Martinez, Valérie, et al.
Publicado: (2013)

Lenvatinib recruits cytotoxic GZMK+CD8 T cells in hepatocellular carcinoma
por: Yamada, Tomoharu, et al.
Publicado: (2023)

Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis
por: Kawagishi, Naoki, et al.
Publicado: (2018)

A Polymorphism in IL28B Distinguishes Exposed, Uninfected Individuals From Spontaneous Resolvers of HCV Infection
por: Knapp, Susanne, et al.
Publicado: (2011)

Corrigendum: Influence of IL28B and MxA gene polymorphisms on HCV clearance in Han Chinese population
por: Zang, Feng, et al.
Publicado: (2019)

IL28A protein homotetramer structure is required for autolysosomal degradation of HCV-NS5A in vitro
por: Ma, Yuan-yuan, et al.
Publicado: (2020)

Neoadjuvant Use of Oncolytic Herpes Virus G47Δ Enhances the Antitumor Efficacy of Radiofrequency Ablation
por: Yamada, Tomoharu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8kq9mtstt0r85af5mb73uc4bhd